Menu

News and insights

Updates from Syncona and our portfolio companies

Filter by:

Type

Topic

Company

Reset
Syncona

06.05.2020

Corporate Presentation

Download (2.56Mb)
Syncona

30.04.2020

Danny Bar-Zohar joins Syncona as Partner

Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life sciences, announces the appointment of Danny Bar-Zohar, M.D., as Syncona Partner, from 17 April 2020. In this role, Danny will leverage his expertise in clinical development, regulatory environments and medical affairs to help Syncona further build and establish its portfolio of life science companies.
Syncona

23.03.2020

COVID-19: Syncona Business Update

Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, today provides an update on its business following the outbreak of the COVID-19 pandemic.
Syncona

04.02.2020

Lorenz Mayr Appointed as Entrepreneur in Residence

Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life sciences, announces the appointment of Lorenz Mayr, Ph.D. as Entrepreneur in Residence, from 1 January 2020. In this role, he will have a particular focus on sourcing new Syncona companies, developing and driving portfolio company business plans and strategy.
Syncona

04.02.2020

Capital Markets Day Presentation

Download (3.45Mb)
Syncona

15.10.2019

Found, Build and Fund

Syncona’s Chief Executive, Martin Murphy and Syncona Partner, Elisa Petris describe Syncona’s strategy to Found, Build and Fund global leaders in life science.
Syncona

14.06.2018

Syncona Expands Global Leadership Position In Gene Therapy With Foundation Of New Companies

Syncona further strengthens position in gene therapy; foundation of SwanBio and Orbit Biomedical takes gene therapy group to five companies.